Free Trial

CenterBook Partners LP Raises Holdings in Stevanato Group S.p.A. (NYSE:STVN)

Stevanato Group logo with Medical background

Key Points

  • CenterBook Partners LP increased its stake in Stevanato Group S.p.A. by 10.4% during the first quarter, owning a total of 118,065 shares worth approximately $2.4 million at the end of the reporting period.
  • Analysts have a consensus rating of "Moderate Buy" for Stevanato Group, with an average target price of €25.70 ($29.88), indicating positive market sentiment.
  • Stevanato Group's stock has seen a growth of 4.4% recently, with shares opening at €24.11 ($28.03), reflecting a strong performance amid a market cap of $7.3 billion.
  • Want stock alerts on Stevanato Group? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

CenterBook Partners LP boosted its stake in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 10.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 118,065 shares of the company's stock after acquiring an additional 11,142 shares during the quarter. CenterBook Partners LP's holdings in Stevanato Group were worth $2,411,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. Blair William & Co. IL raised its position in Stevanato Group by 642.9% during the first quarter. Blair William & Co. IL now owns 159,032 shares of the company's stock valued at $3,247,000 after acquiring an additional 137,625 shares in the last quarter. PNC Financial Services Group Inc. raised its position in Stevanato Group by 62.4% during the first quarter. PNC Financial Services Group Inc. now owns 9,182 shares of the company's stock valued at $187,000 after acquiring an additional 3,528 shares in the last quarter. US Bancorp DE increased its position in shares of Stevanato Group by 18.1% in the first quarter. US Bancorp DE now owns 10,072 shares of the company's stock valued at $206,000 after buying an additional 1,545 shares in the last quarter. Premier Fund Managers Ltd purchased a new stake in shares of Stevanato Group in the first quarter valued at approximately $709,000. Finally, LPL Financial LLC increased its position in shares of Stevanato Group by 35.4% in the first quarter. LPL Financial LLC now owns 116,060 shares of the company's stock valued at $2,250,000 after buying an additional 30,339 shares in the last quarter.

Stevanato Group Price Performance

Shares of STVN traded down €0.70 ($0.81) during trading hours on Friday, hitting €23.50 ($27.33). 364,300 shares of the stock were exchanged, compared to its average volume of 339,651. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.26 and a current ratio of 1.79. Stevanato Group S.p.A. has a 12-month low of €17.12 ($19.91) and a 12-month high of €28.00 ($32.56). The company has a market cap of $7.12 billion, a price-to-earnings ratio of 43.52, a price-to-earnings-growth ratio of 2.44 and a beta of 0.55. The stock's 50-day moving average price is €24.52 and its two-hundred day moving average price is €22.44.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on STVN. Stephens upgraded Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. William Blair restated an "outperform" rating on shares of Stevanato Group in a research report on Monday, June 30th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Stevanato Group has a consensus rating of "Moderate Buy" and an average price target of €25.13 ($29.22).

Read Our Latest Analysis on STVN

Stevanato Group Company Profile

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

See Also

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines